Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000939767-21-000097
Filing Date
2021-11-02
Accepted
2021-11-02 16:18:47
Documents
72
Period of Report
2021-10-01

Document Format Files

Seq Description Document Type Size
1 10-Q exel-20211001.htm   iXBRL 10-Q 1770464
2 EX-31.1 exel20210930exhibit311.htm EX-31.1 8862
3 EX-31.2 exel20210930exhibit312.htm EX-31.2 8741
4 EX-32.1 exel20210930exhibit321.htm EX-32.1 6845
10 GRAPHIC exel-20211001_g1.jpg GRAPHIC 116418
  Complete submission text file 0000939767-21-000097.txt   7568147

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exel-20211001.xsd EX-101.SCH 50510
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT exel-20211001_cal.xml EX-101.CAL 66501
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT exel-20211001_def.xml EX-101.DEF 219551
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exel-20211001_lab.xml EX-101.LAB 530895
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exel-20211001_pre.xml EX-101.PRE 361365
11 EXTRACTED XBRL INSTANCE DOCUMENT exel-20211001_htm.xml XML 1368585
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30235 | Film No.: 211371566
SIC: 2836 Biological Products, (No Diagnostic Substances)